Looking Beyond Mammals to Microbes for Tomorrow’s Drugs

(DGIwire) – In order to create the current generation of biologic drugs, manufacturers have largely depended on cell lines derived from mammals—specifically, the Chinese hamster ovary (CHO) cell. But as Mark Emalfarb, President and CEO of Dyadic International, wrote recently on TheMedicineMaker.com, it may be time to move from mammals to microbes for the next […]

close